Background: The ‘normal appearing white matter’ (NAWM) in multiple sclerosis (MS) is known to be abnormal using quantitative magnetic resonance (MR) techniques. The aetiology of the changes in NAWM remains debatable.
Objective: To investigate whether high-field and ultra high-field T1-weighted magnetization prepared rapid acquisition gradient echo (MPRAGE) MRI enables detection of MS white matter lesions in areas defined as NAWM using high-field T2-weighted fluid attenuation inversion recovery (FLAIR) MRI; that is, to ascertain whether undetected lesions are likely contributors to the burden of abnormality in similarly defined NAWM.
Methods: Fourteen MS patients underwent MRI scans using 3T FLAIR and MPRAGE and 7 Tesla (7T) MPRAGE sequences. Independent observers identified lesions on 3T FLAIR and (7T and 3T) MPRAGE images. The detection of every individual lesion was then compared for each image type.
Results: We identified a total of 812 white matter lesions on 3T FLAIR. Using 3T MPRAGE, 186 additional lesions were detected that were not detected using 3T FLAIR. Using 7T MPRAGE, 231 additional lesions were detected that were not detected using 3T FLAIR.
Conclusions: MRI with 3T and 7T MPRAGE enables detection of MS lesions in areas defined as NAWM using 3T FLAIR. Focal MS lesions contribute to the abnormalities known to exist in the NAWM.
FilippiMTortorellaCBozzaliM. Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques. Mult Scler1999; 5: 273–282.
2.
EvangelouNKonzDEsiriMMSmithSPalaceJMatthewsPM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain2000; 123: 1845–1849.
3.
EvangelouNKonzDEsiriMMSmithSPalaceJMatthewsPM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain2001; 124: 1813–1820.
4.
DavieCABarkerGJThompsonAJToftsPSMcDonaldWIMillerDH. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J. Neurol Neurosurg Psychiatr1997; 63: 736–742.
5.
FilippiMIannucciGTortorellaCMinicucciLHorsfieldMAColomboB. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology1999; 52: 588–594.
6.
MoreauTColesAWingMIsaacsJHaleGWaldmannH. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain1996; 119: 225–237.
7.
ZeisTGraumannUReynoldsRSchaeren-WiemersN. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain2008; 131: 288–303.
8.
MoraalBRoosendaalSDPouwelsPJVrenkenHvan SchijndelRAMeierDS. Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis. Eur Radiol2008; 18: 2311–2320.
9.
KeiperMDGrossmanRIHirschJABolingerLOttILMannonLJ. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. AJNR Am J Neuroradiol1998; 19: 1489–1493.
10.
KolliaKMaderwaldSPutzkiNSchlamannMTheysohnJMKraffO. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol2009; 30: 699–702.
11.
NewcombeJHawkinsCPHendersonCLPatelHAWoodroofeMNHayesGM. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain1991; 114: 1013–1023.
12.
SchmiererKWheeler-KingshottCAMTozerDJBoulbyPAParkesHGYousryTA. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med2008; 59: 268–277.
13.
SchmiererKParkesHGSoPAnSFBrandnerSOrdidgeRJ. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain2010; 133: 858–867.
14.
MaineroCBennerTRaddingAvan der KouweAJensenRRosenBR. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology2009; 73: 941–948.
15.
KangarluABourekasECRay-ChaudhuryARammohanKW. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol2007; 28: 262–266.
16.
TallantyreECBrookesMJDixonJEMorganPSEvangelouNMorrisPG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology2008; 70: 2076–2078.
17.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
18.
JenkinsonMBannisterPBradyMSmithS. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage2002; 17: 825–841.
19.
Ruiz-PeñaJLPiñeroPSellersGArgenteJCasadoAForondaJ. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy. BMC Neurol2004; 4: 8.
20.
Sastre-GarrigaJIngleGTChardDTRamió-TorrentàLMcLeanMAMillerDH. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol2005; 62: 569–573.
21.
KhaleeliZSastre-GarrigaJCiccarelliOMillerDHThompsonAJ. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry2007; 78: 1076–1082.
22.
NeemaMGoldberg-ZimringDGussZDHealyBCGuttmannCRGHoutchensMK. 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage2009; 46: 633–641.
FilippiMAgostaF. Magnetization transfer MRI in multiple sclerosis. J Neuroimaging2007; 17(Suppl 1): 22S–26S.
25.
De StefanoNFilippiM. MR spectroscopy in multiple sclerosis. J Neuroimaging2007; 17(Suppl 1): 31S–35S.
26.
SajjaBRWolinskyJSNarayanaPA. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am2009; 19: 45–58.
27.
Castriota-ScanderbegAFasanoFFilippiMCaltagironeC. T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler2004; 10: 556–561.
28.
GriffinCMChardDTParkerGJMBarkerGJThompsonAJMillerDH. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol2002; 249: 193–199.
29.
MolyneuxPDTubridyNParkerGJBarkerGJMacManusDGToftsPS. The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. AJNR Am J Neuroradiol1998; 19: 1715–1720.
30.
BastianelloSBozzaoAPaolilloAGiugniEGasperiniCKoudriavtsevaT. Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol1997; 18: 699–704.
31.
KatesRAtkinsonDBrant-ZawadzkiM. Fluid-attenuated inversion recovery (FLAIR): clinical prospectus of current and future applications. Top Magn Reson Imaging1996; 8: 389–396.
32.
BoggildMDWilliamsRHaqNHawkinsCP. Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis. Neuroradiology1996; 38(Suppl 1): S10–S13.
33.
FilippiMHorsfieldMAHajnalJVNarayanaPAUdupaJKYousryTA. Quantitative assessment of magnetic resonance imaging lesion load in multiple sclerosis. J Neurol Neurosurg Psychiatry1998; 64(Suppl 1): S88–S93.
34.
DamianMSSchillingGBachmannGSimonCStöpplerSDorndorfW. White matter lesions and cognitive deficits: relevance of lesion pattern?. Acta Neurol Scand1994; 90: 430–436.
35.
MoriartyDMBlackshawAJTalbotPRGriffithsHLSnowdenJSHillierVF. Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images. AJNR Am J Neuroradiol1999; 20: 1956–1962.
